ISLAMABAD:
Drug Regulatory Authority of Pakistan (DRAP), which is responsible for monitoring the quality of medicine in the country, is not recognised by the World Health Organisation (WHO) in a startling revelation, resulting in Pakistani companies being unable to export to developed countries.
A major hurdle in the recognition of DRAP is the Federal Drug Surveillance Laboratory (FDSL), a credible drug testing lab which is mandatory for recognition, and could not be made functional.
While the building was constructed and equipment purchased, a medical college was reportedly established in the building.
National Health Services (NHS) Minister Saira Afzal Tarar claimed that she has been making efforts to take possession of the laboratory building, located in Chak Shahzad and following the establishment of the laboratory, the Drap will be recognised by the WHO.
The Drap was established under the Drap Act 2012 for effective coordination and enforcement of the Drugs Act 1976. The authority is responsible for ensuring the quality of drugs all over the country; moreover it is mandated to ensure the availability of medicines at affordable rates.
